// App-Quantinova.ai

PB2151 : Influence of Tumor Site on Clinical Outcomes in Cancer Patients with Venous Thromboembolism. Insights from the Prospective PREDICARE Cohort Study

Researchers

Presenter

  • P. Girard

Principal Investigators

  • S. Laporte

  • C. Chapelle

  • A. Lamblin

  • G. Meyer

Medical Centers

  • Institut Mutualiste Montsouris, Paris, France

  • F-CRIN INNOVTE Network, Saint Etienne, France

  • CHU Saint-Etienne, Saint Etienne, France

  • SAINBIOSE, INSERM U 1059, Université Lyon, Saint‐Etienne, France

  • CHU Saint-Etienne, Saint Etienne, France

  • Leo-Pharma, Voisins le Bretonneux, France

  • Hopital European Georges Pompidou, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Tinzaparin

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • NCT03099031

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved